Skip to main content
Home

Main navigation

  • Our Company
    • Who we are
    • Senior Leadership Team
    • Board of Directors
    • Scientific Advisory Committee
    • Awards and Recognition
    • Virtual Company Tour
  • Our Solutions
    • AGROBODY Foundry™
    • Product pipeline
    • Evoca™
  • Investors
    • Press releases
    • Financial information
    • Stock Information
    • Shareholder information
    • Corporate governance
    • Events
    • Presentations
    • Fact sheets
    • IPO
  • Partnering
  • News & Events
    • Press releases
    • Events
    • Stay in touch
    • Message from our CEO
  • Careers
    • Open Positions
    • Vision & Values
    • What our employees say
    • Benefits and wellbeing
  • Contact

User account menu

  • Log in

Press releases

Go back to Investors overview
October 1, 2024

Biotalys Expands R&D Pipeline with New Biofungicide Program

PDF icon
EN
PDF icon
NL
September 17, 2024

Biotalys Granted Patents for EVOCA in Both Europe and the United States

PDF icon
EN
PDF icon
NL
September 2, 2024

Biotalys Receives Approval for Large-Scale Demonstration Trials of EVOCA in the Netherlands

PDF icon
EN
PDF icon
NL
August 22, 2024

Biotalys Reports Half-Year 2024 Financial Results and Business Highlights

PDF icon
EN
PDF icon
NL
August 21, 2024

Biotalys Named Sustainable Crop Protection Company of the Year

PDF icon
EN
PDF icon
NL
August 5, 2024

Biotalys Notice of Half Year 2024 Results and Business Highlights

PDF icon
EN
PDF icon
NL
May 2, 2024

Biotalys Starts Field Trials for Second Biofungicide

PDF icon
EN
PDF icon
NL
April 30, 2024

Biotalys Appoints Laura J. Meyer to Board of Directors

PDF icon
EN
PDF icon
NL
April 23, 2024

Results of the Ordinary and Extraordinary Shareholders’ Meeting

PDF icon
EN
PDF icon
NL
March 29, 2024

Results of the Special Shareholders’ Meeting

PDF icon
EN
PDF icon
NL
March 20, 2024

Invitation to the ordinary general shareholders meeting and an extraordinary shareholders meeting

PDF icon
EN
PDF icon
NL
March 18, 2024

Biotalys and Novonesis announce manufacturing and commercialisation partnership for EVOCA NG

PDF icon
EN
PDF icon
NL
February 26, 2024

Invitation to a Special Shareholders’ Meeting

PDF icon
EN
PDF icon
NL
February 22, 2024

Biotalys Reports Full-Year 2023 Financial Results and Business Highlights

PDF icon
EN
PDF icon
NL
February 8, 2024

Biotalys Enters into Academic Collaborations with Key Scientific Leaders in Europe and U.S.

PDF icon
EN
PDF icon
NL

Pagination

  • Previous page <
  • Page 1
  • Current page 2
  • Page 3
  • …
  • Next page >

Social Menu

  • Twitter
  • LinkedIn
  • Email

Footer navigation (primary)

  • Our Company
    • Who we are
    • Senior Leadership Team
    • Board of Directors
    • Scientific Advisory Committee
  • Our Solutions
    • AGROBODY Foundry™
    • Product pipeline
  • Investors

Footer navigation (secondary)

  • Partnering
  • Media
    • Press releases
    • Events
    • Download section
    • Stay in touch
  • Contact

Home

Biotalys NV
Buchtenstraat 11
Ghent 9051, Belgium
Phone: +32 (0)9 274 5400

info@biotalys.com

© Copyright 2025 Biotalys NV | Privacy Policy | General Purchasing Conditions